Ritsu Yamamoto
Overview
Explore the profile of Ritsu Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuda H, Ito Y, Todo Y, Iba T, Tasaka K, Sutou Y, et al.
Reprod Med Biol
. 2018 Jan;
17(1):29-35.
PMID: 29371818
Purpose: To define the median endometrial thickness (ET) in office gynecology is thought to be important for clinical practice. However, there are few reports about ET that have included the...
2.
Todo Y, Yamamoto R, Minobe S, Suzuki Y, Takeshi U, Nakatani M, et al.
Gynecol Oncol
. 2010 Jul;
119(1):60-4.
PMID: 20638109
Objective: The aim of this study was to determine the incidence rate of lower-extremity lymphedema after systematic lymphadenectomy in patients with uterine corpus malignancies and to elucidate risk factors for...
3.
Yamamoto R, Yamamoto T
Int J Clin Oncol
. 2007 Dec;
12(6):463-8.
PMID: 18071866
Background: Complex decongestive physiotherapy (CDP) consists of a two-phase treatment program and is the international standard therapy for lymphedema. However, this therapy is not performed at most hospitals in Japan....
4.
Yamamoto R, Ohkouchi T, Tabata K, Ebina Y, Watari H, Kudo M, et al.
Acta Obstet Gynecol Scand
. 2005 Nov;
84(12):1145-9.
PMID: 16305698
Background: The mechanisms of the increase in the percentage of alpha-fetoproteins (AFPs) that strongly binds to Lens culinaris agglutinin (AFP-L3) in pregnancies with a trisomy 21 fetus have not been...
5.
Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Yamada H, Yamamoto R, et al.
Cancer
. 2005 Sep;
104(9):1924-30.
PMID: 16134181
Background: Ovarian clear cell adenocarcinoma is associated with one of the poorest prognoses among human epithelial ovarian cancers. The authors hypothesized that Wilms tumor suppressor 1 gene (WT1) sense and...
6.
Sakuragi N, Watari H, Ebina Y, Yamamoto R, Steiner E, Koelbl H, et al.
Int J Cancer
. 2005 Apr;
116(4):514-9.
PMID: 15825182
In addition to the loss of function, mutant p53 can possess a dominant-negative effect on wild-type p53 and may also exert gain-of-function activity. It is not clear whether the functional...
7.
Todo Y, Minobe S, Sasaki M, Yamamoto R, Sakuragi N
Gynecol Oncol
. 2005 Mar;
97(1):223-7.
PMID: 15790463
Background: There has been no report on the effectiveness of combination chemotherapy consisting of paclitaxel and carboplatin for pure-type ovarian squamous cell carcinoma (POSCC). Case: A 56-year-old Japanese woman diagnosed...
8.
Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N
Gynecol Oncol
. 2005 Feb;
96(3):651-7.
PMID: 15721407
Objective: The aim of this study was to determine pathologic variables associated with disease-specific survival of node-positive patients with endometrial carcinoma treated with combination of surgery including pelvic and para-aortic...
9.
Yamamoto R, Yonesaka A, Nishioka S, Watari H, Hashimoto T, Uchida D, et al.
Radiother Oncol
. 2004 Nov;
73(2):219-22.
PMID: 15542169
The feasibility and accuracy of high dose three-dimensional conformal boost (3DCB) using three internal fiducial markers and a two-orthogonal X-ray set-up of the real-time tumor-tracking system on patients with gynecological...
10.
Ebina Y, Yamamoto R, Sakuragi N
Nihon Rinsho
. 2004 Nov;
62 Suppl 10:565-9.
PMID: 15535309
No abstract available.